Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study

Lignende værker

• Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen
  af: Onishi, Yukiko, et al.
  Udgivet: (2020)
• Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies
  af: Suzuki, Shuichi, et al.
  Udgivet: (2017)
• Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open‐label, phase III, non‐inferiority study
  af: Araki, E., et al.
  Udgivet: (2015)
• Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled Trial
  af: Inoue, Megumi, et al.
  Udgivet: (2019)
• Efficacy and safety of dulaglutide: a novel once-weekly glucagon-like peptide-1 analogue
  af: A. S. Pogorelova, et al.
  Udgivet: (2018-03-01)